**Ongoing measles transmission in unvaccinated populations continues to drive rapid case growth.** As of early September 2026, the CDC reported 3,294 confirmed U.S. cases year-to-date, with 160 new cases added in the most recent week—primarily from large, prolonged outbreaks in Pennsylvania (over 670 cases), South Carolina, Utah, and several other states. Roughly 95% of cases link to outbreaks, 94% involve unvaccinated or unknown-status individuals, and 63% occur in those under 20 years old. Measles’ extreme contagiousness sustains chains of transmission even as public health responses continue. Weekly CDC and state surveillance updates through late September will determine the final count by the 30th, with recent trends indicating further increases before month-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis d'ici le 30 septembre ?
Cas de rougeole aux États-Unis d'ici le 30 septembre ?
NOUVEAU
30 sept. 2026
3800+
8%
4000+
4%
3300+
100%
3400+
99%
3500+
98%
$8,257 Vol.
3800+
$134 Vol.
8%
4000+
$96 Vol.
4%
3300+
$277 Vol.
100%
3400+
$294 Vol.
99%
3500+
$1,021 Vol.
98%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Ongoing measles transmission in unvaccinated populations continues to drive rapid case growth.** As of early September 2026, the CDC reported 3,294 confirmed U.S. cases year-to-date, with 160 new cases added in the most recent week—primarily from large, prolonged outbreaks in Pennsylvania (over 670 cases), South Carolina, Utah, and several other states. Roughly 95% of cases link to outbreaks, 94% involve unvaccinated or unknown-status individuals, and 63% occur in those under 20 years old. Measles’ extreme contagiousness sustains chains of transmission even as public health responses continue. Weekly CDC and state surveillance updates through late September will determine the final count by the 30th, with recent trends indicating further increases before month-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Sep 1, 2026, 4:19 PM ET
Volume
$8,257Date de fin
1 oct. 2026Marché ouvert
Sep 1, 2026, 4:19 PM ETRésolveur
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Ongoing measles transmission in unvaccinated populations continues to drive rapid case growth.** As of early September 2026, the CDC reported 3,294 confirmed U.S. cases year-to-date, with 160 new cases added in the most recent week—primarily from large, prolonged outbreaks in Pennsylvania (over 670 cases), South Carolina, Utah, and several other states. Roughly 95% of cases link to outbreaks, 94% involve unvaccinated or unknown-status individuals, and 63% occur in those under 20 years old. Measles’ extreme contagiousness sustains chains of transmission even as public health responses continue. Weekly CDC and state surveillance updates through late September will determine the final count by the 30th, with recent trends indicating further increases before month-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$8,257Date de fin
1 oct. 2026Marché ouvert
Sep 1, 2026, 4:19 PM ETRésolveur
0x65070BE91...**Ongoing measles transmission in unvaccinated populations continues to drive rapid case growth.** As of early September 2026, the CDC reported 3,294 confirmed U.S. cases year-to-date, with 160 new cases added in the most recent week—primarily from large, prolonged outbreaks in Pennsylvania (over 670 cases), South Carolina, Utah, and several other states. Roughly 95% of cases link to outbreaks, 94% involve unvaccinated or unknown-status individuals, and 63% occur in those under 20 years old. Measles’ extreme contagiousness sustains chains of transmission even as public health responses continue. Weekly CDC and state surveillance updates through late September will determine the final count by the 30th, with recent trends indicating further increases before month-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes